The Wall Street Journal reports that ApniCure Inc, the maker of a new treatment for obstructive sleep apnea treatment, has raised more than $15 million for financing.

ApniCure Inc., which makes an obstructive sleep apnea treatment that doesn’t require a mask, has raised $15.8 million toward a $17.4 million financing, according to a regulatory filing. The company previously raised capital from Capricorn Investment Group, Kleiner Perkins Caufield & Byers and U.S. Venture Partners. In obstructive sleep apnea, the airway narrows or becomes partially blocked. Snoring is a symptom of the condition, which can lead to complications such as drowsiness and cardiovascular problems. Continuous positive airway pressure, which uses air pressure to keep the airway open, is effective treatment. Many patients resist it because it requires wearing a mask.

Read the full story at